Qualifications: MD, MRCS, MS, PG Dip, FRCS

Consultant Oncoplastic Breast Surgeon Mo Salhab works at Bradford Teaching Hospitals and the Yorkshire Clinic in Cottingley. He is also an Honorary Clinical Senior Lecturer at the University of Leeds.

Mr Salhab graduated from medical school (MD) in 1996, before going on to basic and higher surgical training in the UK, and surgical training in oncoplastic breast surgery in London, Yorkshire, Paris, and Brussels. ​

In 2011, he was awarded the degree of Master of Surgery (MS) from the University of London for his research in the field of breast cancer molecular biology. He has published widely in the field of breast cancer and presented his work at national and international meetings. He also obtained a Postgraduate Diploma in Oncoplastic Breast Surgery from the University of East Anglia after completing a two-year course in Oncoplastic Breast Surgery. In 2013 he completed his accreditation and gained the Certificate of Completion of Training (CCT) before being appointed to his current role at Bradford Teaching Hospitals.

Mr Salhab is a fellow of the Royal College of Surgeons of England and a member of both the Association of Breast Surgery and the ​European Society of Surgical Oncology.

Clinical interests: 

Mr Salhab specialises in the diagnosis and management of diseases of the breast, including:

  • Benign breast disease, breast pain, nipple discharge, and breast infections
  • Family history, breast cancer risk evaluation, and genetic breast disease
  • Breast cancer screening diagnosis and management and  sentinel node biopsy
  • Immediate and delayed breast reconstruction and nipple reconstruction
  • Cosmetic breast surgery (augmentation, implant exchange, breast reduction, and uplift)
  • Correction of breast abnormalities, nipple inversion, and tuberous breasts
  • Correction of breast deformities by fat transfer and lipofilling
  • Male breast problems and gynaecomastia

Selected publications:

  • Glassman D1, Hignett , Rehman S, Linforth R, Salhab M. Adjuvant Endocrine Therapy for Hormone-positive Breast Cancer, Focusing on Ovarian Suppression and Extended Treatment: An Update. Anticancer Res. 2017 Oct;37(10):5329-5341
  • Shaheed SU, Tait C, Kyriacou K, Linforth R, Salhab M, Sutton C Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer. Clin Proteomics. 2018 Jan 11;15:3. doi: 10.1186/s12014-017-9179-4. eCollection 2018
  • Shaheed SU, Tait C, Kyriacou K, Mullarkey J, Burrill W, Patterson LH, Linforth R, Salhab M, Sutton CW. Nipple aspirate fluid-A liquid biopsy for diagnosing breast health. Proteomics Clin Appl. 2017 May 10. doi: 10.1002/prca.201700015
  • Hignett S, Tait C, Rigby K, Carder P, Linforth R, Salhab M. Does micro-invasion with DCIS on core biopsy from breast patients indicate whether sentinel lymph node biopsy (SLNB) should be performed? EJSO, 2015, 41, 6, S35
  • Hogan B, Chan S, Salhab M, Linforth R, Tait C. Reducing margin width following breast conserving surgery increases risk of residual disease in the breast.  DOI: http://dx.doi.org/10.1016/j.ejso.2014.08.181
  • Salhab M, Elghazawy R, Tait C, Linforth R. Radiological Staging of Symptomatic High Risk Breast Cancer Patients is of Limited Value. Euro J  Surg Onco,  39, 5, May 2013, 479
  • Thekkinkattil DK1, Salhab M, McManus PL. Feasibility of Autologous Fat Transfer for Replacement of Implant Volume in Complicated Implant-Assisted Latissimus Dorsi Flap Breast Reconstruction. Ann Plast Surg. 2013 Oct 21. [Epub ahead of print]
  • Salhab M, Patani N, Mokbel K. Sentinel Lymph Node Micrometastasis In Human Breast Cancer. An Update. Surg Oncol. 2011 Dec;20(4):e195-206
  • Salhab M, Mokbel K. The role of aromatase and other oestrogen producing enzymes in mammary carcinogenesis. Metastasis of Breast Cancer­, Springer Publishers ISBN: 978-1-4020-5866